web name
  • Home
  • About Us
    • Survey
    • Culture
    • Course
    • Video
    About Us

    Scientific research, production and sales as one of the innovative pharmaceutical group enterprises, is the country's largest liver health drug research and development and production base.

  • News
    • Company
    • Industry
    News

    Future development, will continue to strengthen the core competitiveness of the building, so that the company's research and development has always been in line with the international frontier.

  • Product
    • Antiviral
    • Liver
    • Tumor
    • Breathing
    • Antibiotic
    • Hypoglycemic
    • Bone
    • Digestion
    Product

    Treatment involves liver disease, cancer, diabetes, respiratory, cardiovascular and cerebrovascular diseases, anti infection, digestive, nervous and other diseases.

  • Innovate
  • Responsibility
    • Idea
    • Commonweal
    • Development
    • Presentation
    Responsibility

  • Job
  • Contact Us
    • Company
      Company
    • Industry
      Industry
    You are here: Home  >> News  >> Company  >> View Details

    Company

    Pharmaceutical electricity supplier billion tuyere where to find, look at the four pre judgment!

    From: web name  Date:2017-01-06 09:46:47  Hits:351  Belong to:Company
    2016 pharmaceutical electricity supplier B2C market showed a trend of development is expected to be relatively loose policy in 2017, the market growth is relatively slow. By 2020, the pharmaceutical electricity supplier market will grow to more than 100 billion yuan market.

    2016 is over, 2017 has been opened. About 2016, the pharmaceutical business industry common reaction is the environment is not good, and do not say the Internet operating food and drug supervision and management measures "issued in 2014 (Draft)" has yet to come, in anticipation of the 2015 industrial electricity supplier for pharmaceutical peak in 2016 at the same time, industry environment and policy all the way down, is not a small the impact to the entire pharmaceutical business industry. Reviewing the past, this year, the pharmaceutical business B2C market showing a trend of contradiction, a policy investment environment by tightening; on the other hand, according to early November 2016 CFDA smeri released on 2016 online pharmacy sales volume data is expected in 2016, B2C pharmaceutical business market will reach 28 billion 500 million yuan, compared with growth with $14 billion 400 million in 2015 97.6%, the anti ultra loose environment (2015 85.11%).
    Previous:Public hospitals are keen to import expensive medical devices, expensive"
    Next:Chinese hepatitis B drug market into "fat" opened the prelude to the battle for pharmaceutical compa

    Link:

    • sohu.com
    • yahoo.com
    • netease.com
    • 163.com
    • QQ
    • sogou.com
    • sina.com.cn
    • baidu.com
    • china news
    • tencent
    • sogou
    • sina
    • sohu
    • yahoo
    • google
    • baidu
    Technical Support:ShenYingSoft your company Copyright 2023-2028 ICP 123456789